标准研讨

分析方法持续确认指标和评估方式的探讨

展开
  • 1.北京民海生物科技有限公司,北京 102609;
    2.中国食品药品检定研究院 国家药品监督管理局化学药品质量研究与评价重点实验室,北京 102629
第一作者 李 娜 Tel:1861240509;E-mail:lln0809@163.com
杜 颖 Tel:(010)53851583;E-mail:dy9630@ nifdc.org.cn
* 聂晓齐 Tel:(010)59613570;E-mail:niexiaoqi@biominhai.com
谭德讲 Tel:(010)53851589;E-mail:tandj@nifdc.org.cn

收稿日期: 2023-11-20

  网络出版日期: 2024-06-20

Discussion the ongoing verification indicators and evaluation approachs of analytical procedure

Expand
  • 1. Beijing Minhai Biotechnology Co., Ltd., Beijing 102609, China;
    2. National Institutes for Food and Drug Control, NMPA Key Lab for Quality Research and Evaluation of Chemical Drug, Beijing 102629, China

Received date: 2023-11-20

  Online published: 2024-06-20

摘要

分析方法性能持续确认是确保方法在完成验证后持续满足其预期用途的过程。本文在前期研究的基础上,进一步探讨方法性能持续确认的指标(包括系统适用性指标和报告值等)和实施分析工具(控制图),并以示例演示方法性能持续确认的具体操作步骤。希望本文可以为药品领域,特别是企业和监管部门在方法确认的科学化、规范化方面提供新的思路。

本文引用格式

李娜, 杜颖, 耿颖, 靳朝晖, 曲晓蒙, 聂晓齐, 谭德讲 . 分析方法持续确认指标和评估方式的探讨[J]. 药物分析杂志, 2024 , 44(5) : 916 -920 . DOI: 10.16155/j.0254-1793.2024.05.21

Abstract

Ongoing procedure performance verification (OPPV) of an analytical procedure is the process of ensuring it continues to meet its intended use after completion of validation. On the basis of previous studies, this paper further discussed the indicators of ongoing procedure performance verification (including system suitability indicators and reported values, etc.) and the implementation of analysis tools (control charts), and demonstrated the specific operation steps of ongoing procedure performance verification with examples. It is hoped that this paper will provide new ideas for the accurate and standardized procedure verification in the pharmaceutical field, especially in the enterprises and regulatory departments.

参考文献

[1] USP 46-NF 41 <1220> Analytical Procedure Life Cycle[S]. 2022
[2] ICH Q14 Analytical Procedure Development [EB/OL]. (2022-08-24) [2023-09-08] https://www.ema. europa. eu/en/ich-q14-analytical-procedure-development-scientific-guideline
[3] ISO 5725 Accuracy (Trueness and Precision) of Measurement Methods and Results—Part 6:Use in Practice of Accuracy Values[S]. 1994
[4] 中国食品药品检验研究院.中国药品检验标准操作规范[M]. 北京:中国医药科技出版社, 2019:714
National Institutes for Food and Drug Control. Chinese Drug Inspection Standard Operating Standards[M]. Beijing:China Medical Science and Technology Press, 2019:714
[5] 李娜,耿颖,谭德讲,等.分析方法确认和转移的评估标准探讨[J]. 药物分析杂志, 2021, 41(4):675
LI N, GENG Y, TAN DJ, et al. Discussion on the criteria for successful method verification and transfer[J]. Chin J Pharm Anal, 2021, 41(4):675
[6] USP 46-NF 41<1033> Biological Assay Validation [S]. 2022
[7] 李娜,杜颖,刘翠,等.生物活性检测方法的定义及分类辨析[J]. 药物分析杂志,2022, 42(6):931
LI N,DU Y, LIU C, et al. Definition and taxonomy of biological method[J]. Chin J Pharm Anal, 2022, 42(6):931
[8] 中华人民共和国药典2020年版. 四部[S]. 2020:61,206
ChP 2020.Vol Ⅳ[S]. 2020:61,206
[9] ZHU FG. Application of shewhart control charts in the inspection of pharmaceutical manufacturing process[J]. Int J Pharm Chem, 2019, 5(1):1
[10] 李娜,冯国双,段丽,等.OOS管理中的统计分析工具及其应用[J]. 中国食品药品监管, 2021(6):40
LI N, FENG GS, DUAN L, et al. Statistical analysis tools and their applications in OOS management [J]. China Food Drug Adm, 2021(6):40
[11] ICH Q2(R1). Validation of Analytical Procedures:Text and Methodology [S]. 2005
[12] PA/PH/OMCL (21) 26-Statistical analysis of results using CombiStats [EB/OL]. 2021 [2022-05-30]. https://www.edqm.eu/documents/52006/67492/Statistical+analysis+of+results+of+biological+assays+and+tests+-+PA_PH_OMCL+%2821%29+26.pdf/9281bbf2-f852-d0f5-9342-95ff25397946?t=1649409069892
[13] ASTM D6299. Applying Statistical Quality Assurance and Control Charting Techniques to Evaluate Analytical Measurement System Performance[S]. 2020
[14] ISO 7870-2. Control Charts-Part 2:Shewhart Control Charts[S]. 2023
文章导航

/